C.V. Starr & Co’s Celularity CELU Stock Holding History

C.V. Starr & Co’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Hold	764,069	–	–	0.84%	5
2026 Q1	$1.02M	Hold	764,069	–	–	0.53%	5
2025 Q4	$1.58M	Hold	764,069	–	–	0.87%	5
2025 Q3	$1.58M	Hold	764,069	–	–	0.73%	5
2025 Q2	$1.5M	Hold	764,069	–	–	0.78%	5
2025 Q1	$1.32M	Hold	764,069	–	–	1.02%	5
2024 Q4	$1.59M	Buy	+764,069	New	+$1.82M	1.24%	6
2023 Q3	$1.68M	Hold	764,069	–	–	30.59%	2
2023 Q2	$4.05M	Hold	764,069	–	–	50.87%	1
2023 Q1	$4.74M	Hold	764,069	–	–	60.45%	1
2022 Q4	$9.86M	Hold	764,069	–	–	79.64%	1
2022 Q3	$17.6M	Hold	764,069	–	–	83.89%	1
2022 Q2	$26M	Hold	764,069	–	–	89.08%	1
2022 Q1	$66.5M	Buy	764,069 +332,034	+77%	+$19.9M	93.16%	1
2021 Q4	$22.1M	Buy	+432,035	New	+$27.6M	81.56%	1

Other funds holding CELU

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

C.V. Starr & Co's CELU Position: Q2 2026 in Review

C.V. Starr & Co held its Celularity (CELU) position steady in Q2 2026 at 764,069 shares worth $1.58M. The position accounts for 0.84% of the portfolio, ranked #5.

C.V. Starr & Co first reported a position in CELU in Q4 2021 and has held it in 15 quarters since. The position peaked at $66.5M in Q1 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

C.V. Starr & Co held 764,069 shares of Celularity worth $1.58M as of Q2 2026.
C.V. Starr & Co left its Celularity share count unchanged in Q2 2026.
Celularity made up 0.84% of C.V. Starr & Co's portfolio in Q2 2026, its #5 holding.
C.V. Starr & Co first reported a position in Celularity in Q4 2021 and has held it in 15 quarters since.
C.V. Starr & Co's Celularity position peaked at $66.5M in Q1 2022.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on C.V. Starr & Co's 13F filing for Q2 2026, filed 11 Aug 2026.